Development of Novel Micellar-Enhanced High-Throughput Microwell Spectrofluorimetric Method for Quantification of Lorlatinib: Application to In Vitro Drug Release and Analysis of Urine Samples

Lorlatinib (LOR) is a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor drug. The Food and Drug Administration (FDA) has granted an approval for the use of LOR as a first therapeutic intervention for individuals diagnosed with ALK-positive metastatic and advanced non-small-...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hossaini, Abdullah M., Darwish, Hany W., Bakheit, Ahmed H., Darwish, Ibrahim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535339/
https://www.ncbi.nlm.nih.gov/pubmed/37765067
http://dx.doi.org/10.3390/ph16091260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535339/
https://www.ncbi.nlm.nih.gov/pubmed/37765067
http://dx.doi.org/10.3390/ph16091260

Ejemplares similares